Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
Figure 43, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban, or edoxaban (treatment) versus dabigatran (control) (observational) - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update - NCBI Bookshelf
Figure 32, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban, or edoxaban (treatment) versus warfarin (control) (observational) - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update - NCBI Bookshelf
What gastroenterologists should know about direct oral anticoagulants - Digestive and Liver Disease
Evaluation of bleeding in patients receiving direct oral anticoagulant | VHRM
GI bleeding more common with rivaroxaban than other direct oral anticoagulants
Comparison of NOACs in risk of major bleeding in patients with AF. AF =... | Download Scientific Diagram
Better clinical outcomes with DOACs vs. warfarin in patients with NVAF and low body weight - PACE-CME
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke
Libraries Back Pharmacist Pharmacist CE LibraryMTM Certificate ProgramVeterinary Pharmacy Certificate ProgramLaw Library for PharmacistsMedication Safety for Pharmacists Pharmacy Technician Pharmacy Technician LibraryMTM Certificate Program ...
Management of anticoagulation in patients with acute gastrointestinal bleeding - ScienceDirect
Frontiers | Effectiveness and Safety of Under or Over-dosing of Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-analysis of 148909 Patients From 10 Real-World Studies | Pharmacology
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
ESC 2015 Meeting Report
Anticoagulation in the Post-Warfarin Era: Where Are We Today?
What gastroenterologists should know about direct oral anticoagulants - Digestive and Liver Disease
GI bleeding on anticoagulants
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial - ScienceDirect
Systematic review with meta‐analysis: the risk of major gastrointestinal bleeding with non‐vitamin K antagonist oral anticoagulants - Caldeira - 2015 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study - Gastroenterology
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation | Heart
GI bleeding up for new users of rivaroxaban
